Rimantadine (systematic name 1-(1-aminoethyl)adamantane) is an orally administered medicine used to treat, and in rare cases prevent, Influenzavirus A infection. When taken within one to two days of developing symptoms, rimantadine can shorten the duration and moderate the severity of influenza. It is a derivate of adamantane, like a similar drug amantadine. It was approved by the FDA in 1994.
Mechanics
Scientists do not understand why rimantadine works, but believe it inhibits influenza's viral replication, possibly by preventing the uncoating of the virus's protective shells, which are the envelope and capsid. Genetic studies suggest that a virus M2 protein, an ion channel specified by virion M2 gene plays an important role in the susceptibility of influenza A virus to inhibition by rimantadine.
Drug interactions
Taking acetaminophen (Tylenol) or aspirin while taking rimantadine is known to reduce the body's uptake of rimantadine by approximately 12%.[1] Cimetidine also affects the body's uptake of rimantadine.
Adverse effects
Rimantadine can produce gastrointestinal and central nervous system adverse effects. Studies have shown it produces fewer side effects than other anti-viral influenza treatments. Approximately 6% of patients (compared to 6% of patients taking a placebo) reported side effects.[2] Common side effects include:
- nausea
- upset stomach
- nervouseness
- tiredness
- lightheadedness
- trouble sleeping
- difficulty concentrating
External links
The content of this page is retrieved from http://en.wikipedia.org/wiki/Rimantadine under GFDL
